Maged Shenouda - 09 Sep 2026 Form 4 Insider Report for RELMADA THERAPEUTICS, INC. (RLMD)

Reporting relationship: Chief Financial Officer
Issuer ticker: RLMD
Reported as of: 09 Sep 2026
Net transaction value: +$843,990
SEC form: 4
Accepted by SEC: 11 Sep 2026, 07:30:03 UTC
Prior SEC filing: 16 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Maged Shenouda

Key filing fact

Maged Shenouda filed Form 4 for RELMADA THERAPEUTICS, INC. (RLMD) on 11 Sep 2026.

Key facts

This page summarizes Maged Shenouda's Form 4 filing for RELMADA THERAPEUTICS, INC. (RLMD).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 11 Sep 2026, 07:30.

Change

Previous filing in this sequence was filed on 16 Dec 2025.
Current net transaction value: +$843,990.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001658369 Primary reporting owner

Shenouda Maged

Relationship: Chief Financial Officer
Address: C/O RELMADA THERAPEUTICS, INC., 2222 PONCE DE LEON BLVD, 3RD FLOOR, CORAL GABLES
Signature: /s/ Maged Shenouda
Signature date: 11 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RLMD transaction

Common Stock

Purchase

Transaction value: $504,840
Shares: +120,200
Change %: +15%
Price: $4.20
Shares after: 920,200
Date: 09 Sep 2026
Ownership: Direct
Footnotes: F1, F2

RLMD transaction

Common Stock

Purchase

Transaction value: $339,150
Shares: +79,800
Change %: +8.7%
Price: $4.25
Shares after: 1,000,000
Date: 10 Sep 2026
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range.

Footnote F2

Purchase prices range from $4.16 to $4.20 per share, inclusive.